Charles River Labs Intl Stock
Price
Target price
€150.95
€150.95
-0.330%
-0.5
-0.330%
€162.93
03.10.25 / Tradegate
WKN: 939391 / Symbol: CRL / Name: Charles River Lb / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Charles River Labs Intl Stock
The price for the Charles River Labs Intl stock decreased slightly today. Compared to yesterday there is a change of -€0.500 (-0.330%).
With 15 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 162 € shows a slightly positive potential of 7.32% compared to the current price of 150.95 € for Charles River Labs Intl.
Pros and Cons of Charles River Labs Intl in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Charles River Labs Intl vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Charles River Labs Intl | -0.330% | 18.578% | 8.402% | -12.569% | -14.597% | -24.938% | -20.553% |
| Ironwood Pharmaceuticals | 2.290% | 15.517% | 28.846% | -64.171% | -68.095% | -87.248% | -82.368% |
| Novocure Ltd | 3.500% | 12.182% | 19.112% | -5.981% | -57.624% | -84.300% | -87.226% |
| Iovance Biotherapeutics Inc. | 1.760% | 8.764% | 3.394% | -77.535% | -71.680% | -79.214% | -92.728% |
Comments
Charles River Laboratories International (NYSE:CRL) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Show more
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $195.00 price target on the stock, up previously from $165.00.
Show more
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (NYSE:CRL) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for CRL provided by MarketBeat
News
Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call
Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2025 financial results on Wednesday, August 6th, before the market opens. A conference call has been scheduled
Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment
Charles River Laboratories International, Inc. (NYSE: CRL) today announced a recycling program, developed in partnership with international recycling leader TerraCycle®, to give new life to
Charles River Laboratories to Present at William Blair and Jefferies Conferences
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3rd, at 10:00 a.m. CT